Spirox
AcquiredSpirox is a healthcare company in Menlo Park, United States, founded in 2013. It has raised $63.5M across 2 rounds, most recently a $45.0M Series C in March 2016.
- Headquarters
- Menlo Park, California
- Employees
- 11–50
- Founded
- 2013
- Business Model
- B2B
- Website
- spiroxmedical.com
- Total Funding
- $63.5M
- Last Round
- $45.0M Series CMar 2016
- Rounds
- 2
- Acquisition Date
- Jul 2017
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 8 investors for this company. The full record is or through the API.
About
Spirox Medical was a Menlo Park, California-based medical device company that developed the LATERA absorbable nasal implant, a minimally invasive device for treating nasal airway obstruction and improving nasal breathing. The LATERA implant received FDA clearance in 2016. Stryker acquired Spirox Medical in 2017 to expand its ENT portfolio.
Summary
It lists 11–50 employees. It has raised $63.5M in total across 2 rounds, most recently a $45.0M Series C round in Mar 2016. Investors include Aisling Capital, Venrock and Entellus Medical.
Funding & Exit History
Jul 2017
Sign up to see all 3 events
Funding: Series B through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
China's leading blood products manufacturer
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/spirox"><img src="https://indexed.vc/api/badge/company/spirox" alt="Spirox on Indexed.vc" width="260" height="76" /></a>